SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Juanes José A.) "

Sökning: WFRF:(Juanes José A.)

  • Resultat 1-2 av 2
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Maxwell, Tania L., et al. (författare)
  • Global dataset of soil organic carbon in tidal marshes
  • 2023
  • Ingår i: Scientific Data. - : Springer Nature. - 2052-4463. ; 10:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Tidal marshes store large amounts of organic carbon in their soils. Field data quantifying soil organic carbon (SOC) stocks provide an important resource for researchers, natural resource managers, and policy-makers working towards the protection, restoration, and valuation of these ecosystems. We collated a global dataset of tidal marsh soil organic carbon (MarSOC) from 99 studies that includes location, soil depth, site name, dry bulk density, SOC, and/or soil organic matter (SOM). The MarSOC dataset includes 17,454 data points from 2,329 unique locations, and 29 countries. We generated a general transfer function for the conversion of SOM to SOC. Using this data we estimated a median (± median absolute deviation) value of 79.2 ± 38.1 Mg SOC ha−1 in the top 30 cm and 231 ± 134 Mg SOC ha−1 in the top 1 m of tidal marsh soils globally. This data can serve as a basis for future work, and may contribute to incorporation of tidal marsh ecosystems into climate change mitigation and adaptation strategies and policies.
  •  
2.
  • Caronna, Edoardo, et al. (författare)
  • Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
  • 2024
  • Ingår i: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. - 0022-3050 .- 1468-330X.
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Anti-CGRP monoclonal antibodies (anti-CGRP MAbs) are approved and available treatments for migraine prevention. Patients do not respond alike and many countries have reimbursement policies, which hinder treatments to those who might respond. This study aimed to investigate clinical factors associated with good and excellent response to anti-CGRP MAbs at 6 months. Methods European multicentre, prospective, real-world study, including high-frequency episodic or chronic migraine (CM) patients treated since March 2018 with anti-CGRP MAbs. We defined good and excellent responses as >= 50% and >= 75% reduction in monthly headache days (MHD) at 6 months, respectively. Generalised mixed-effect regression models (GLMMs) were used to identify variables independently associated with treatment response. Results Of the 5818 included patients, 82.3% were females and the median age was 48.0 (40.0-55.0) years. At baseline, the median of MHD was 20.0 (14.0-28.0) days/months and 72.2% had a diagnosis of CM. At 6 months (n=4963), 56.5% (2804/4963) were good responders and 26.7% (1324/4963) were excellent responders. In the GLMM model, older age (1.08 (95% CI 1.02 to 1.15), p=0.016), the presence of unilateral pain (1.39 (95% CI 1.21 to 1.60), p<0.001), the absence of depression (0.840 (95% CI 0.731 to 0.966), p=0.014), less monthly migraine days (0.923 (95% CI 0.862 to 0.989), p=0.023) and lower Migraine Disability Assessment at baseline (0.874 (95% CI 0.819 to 0.932), p<0.001) were predictors of good response (AUC of 0.648 (95% CI 0.616 to 0.680)). These variables were also significant predictors of excellent response (AUC of 0.691 (95% CI 0.651 to 0.731)). Sex was not significant in the GLMM models. Conclusions This is the largest real-world study of migraine patients treated with anti-CGRP MAbs. It provides evidence that higher migraine frequency and greater disability at baseline reduce the likelihood of responding to anti-CGRP MAbs, informing physicians and policy-makers on the need for an earlier treatment in order to offer the best chance of treatment success.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-2 av 2
Typ av publikation
tidskriftsartikel (2)
Typ av innehåll
refereegranskat (2)
Författare/redaktör
Sacco, Simona (1)
Ornello, Raffaele (1)
Torelli, Paola (1)
Santos, Rui (1)
Worthington, Thomas ... (1)
Cuadrado-Godia, Elis ... (1)
visa fler...
Pozo-Rosich, Patrici ... (1)
Martins, Isabel Pavã ... (1)
Tassorelli, Cristina (1)
Krause-Jensen, Dorte (1)
Austin, William E. N ... (1)
Craft, Christopher (1)
Jones, Alice R. (1)
Siewert, Matthias B. ... (1)
Caronna, Edoardo (1)
Gallardo, Victor Jos ... (1)
Egeo, Gabriella (1)
Vazquez, Manuel Mill ... (1)
Castellanos, Candela ... (1)
Membrilla, Javier A. (1)
Vaghi, Gloria (1)
Rodriguez-Montolio, ... (1)
Fabra, Neus Fabregat (1)
Sanchez-Caballero, F ... (1)
Sanchez, Alex Jaimes (1)
Munoz-Vendrell, Albe ... (1)
Oliveira, Renato (1)
Garate, Gabriel (1)
Gonzalez-Osorio, Yes ... (1)
Guisado-Alonso, Dani ... (1)
Thunstedt, Cem (1)
Fernandez-Lazaro, Ir ... (1)
Torres-Ferrus, Marta (1)
Alpuente, Alicia (1)
Aurilia, Cinzia (1)
Pere, Raquel Lamas (1)
Castrillo, Maria Jos ... (1)
De Icco, Roberto (1)
Sances, Grazia (1)
Broadhurst, Sarah (1)
Ong, Hui Ching (1)
Garcia, Andrea Gomez (1)
Campoy, Sergio (1)
Sanahuja, Jordi (1)
Cabral, Goncalo (1)
Blasco, Isabel Beltr ... (1)
Waliszewska-Prosol, ... (1)
Pereira, Liliana (1)
Layos-Romero, Almude ... (1)
Luzeiro, Isabel (1)
visa färre...
Lärosäte
Göteborgs universitet (1)
Umeå universitet (1)
Språk
Engelska (2)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (1)
Medicin och hälsovetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy